Reid T. Powell

1.7k citations

38 papers · 949 indexed · h-index 12

Co-authors: Cheryl L. Walker Durga Nand Tripathi Ruhee Dere Arvind Rao Raj K. Pandita Jacqueline Tait-Mulder Vijaya Charaka Jiangwei Zhang
Topics: Cancer-related Molecular Pathways (8 papers)Microtubule and mitosis dynamics (6 papers)Epigenetics and DNA Methylation (5 papers)
Cited by: Cancer Research Molecular Biology Cell Biology
Journals: Cell Journal of Biological Chemistry Nature Communications
Partner nations: United States India Canada

In The Last Decade

Reid T. Powell

32 papers receiving 939 citations

Peers

Countries citing papers authored by Reid T. Powell

Since Specialization

Citations

This map shows the geographic impact of Reid T. Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reid T. Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reid T. Powell more than expected).

Fields of papers citing papers by Reid T. Powell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reid T. Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reid T. Powell. The network helps show where Reid T. Powell may publish in the future.

Co-authorship network of co-authors of Reid T. Powell

This figure shows the co-authorship network connecting the top 25 collaborators of Reid T. Powell. A scholar is included among the top collaborators of Reid T. Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reid T. Powell. Reid T. Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Polo-like kinase 1 inactivation enhances PI3K inhibition-mediated apoptosis of NOTCH1-mutant head and neck squamous cell carcinoma 2025 ·Cancer Letters ·(unknown),Tuhina Mazumdar,Soma Ghosh,(unknown),Reid T. Powell,Yong Park,Li Shen,(unknown),Clifford Stephan,Jing Wang,Andrew G. Sikora,(unknown),Mitchell J. Frederick,Faye M. Johnson	0
2	Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor models 2025 ·Gynecologic Oncology ·(unknown),(unknown),(unknown),Xue Yang,(unknown),(unknown),(unknown),Reid T. Powell,Clifford Stephan,Nghi Nguyen,Yimin Geng,Jian Li,Shiro Takamatsu,(unknown),Lauren Cobb,David M. Gershenson,(unknown),R. Tyler Hillman	0
3	Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors 2024 ·Cancer Research ·(unknown),(unknown),(unknown),(unknown),(unknown),Joseph Celestino,Reid T. Powell,Clifford Stephan,(unknown),(unknown),Shiro Takamatsu,(unknown),Anil K. Sood,David M. Gershenson,P. Andrew Futreal,(unknown),R. Tyler Hillman	1
4	A transgenic mouse model of Down syndrome acute lymphoblastic leukemia identifies targetable vulnerabilities 2024 ·Haematologica ·(unknown),(unknown),(unknown),(unknown),(unknown),Barry Zorman,Pavel Sumazin,(unknown),Gino M Dettorre,Reid T. Powell,Clifford Stephan,Peter J. Davies,Margarita Martinez-Moczygemba,Jun J. Yang,Karen R. Rabin	2
5	EXTH-82. TUMOR ORGANOID PREDICTED THERAPEUTIC RESPONSES TO NOVEL EPIGENETIC DRUGS VIA HIGH-THROUGHPUT SCREENING 2024 ·Neuro-Oncology ·(unknown),(unknown),Reid T. Powell,Clifford Stephan,Xiaonan Li,(unknown)	0
6	Chemical genetic analysis of enoxolone inhibition of Clostridioides difficile toxin production reveals adenine deaminase and ATP synthase as antivirulence targets 2024 ·Journal of Biological Chemistry ·Ravi K. R. Marreddy,(unknown),(unknown),(unknown),Reid T. Powell,Philip Cherian,John J. Bowling,Clifford Stephan,Richard Lee,Julian G. Hurdle	0
7	Cystic fibrosis cell models for high-throughput analysis and drug screening 2024 ·Journal of Cystic Fibrosis ·(unknown),(unknown),Nghi Nguyen,Reid T. Powell,Clifford Stephan,Gang Bao	0
8	Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer 2024 ·npj Breast Cancer ·Reid T. Powell,Amanda L. Rinkenbaugh,Lei Guo,Shirong Cai,Jiansu Shao,Xinhui Zhou,Xiaomei Zhang,Sabrina L. Jeter-Jones,Chunxiao Fu,Yuan Qi,(unknown),Jason B. White,Clifford Stephan,Peter J. Davies,Stacy Moulder,W. Fraser Symmans,Jeffrey T. Chang,Helen Piwnica‐Worms	2
9	Modeling immune checkpoint inhibitor associated myocarditis in vitro and its therapeutic implications 2024 ·SHILAP Revista de lepidopterología ·(unknown),Xinjie Wang,(unknown),(unknown),(unknown),Nicolas L. Palaskas,Mary Sobieski,Nghi Nguyen,Reid T. Powell,Clifford Stephan,Weijia Luo,Chang Jiang	2
10	Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer 2023 ·Molecular Cancer Therapeutics ·Susmita Ghosh,Fan Fan,Reid T. Powell,Jason Roszik,(unknown),Clifford Stephan,Manu Sebastian,(unknown),Alexey V. Sorokin,Philip L. Lorenzi,Scott Kopetz,Lee M. Ellis,Rajat Bhattacharya	5
11	Systematic high-throughput combination drug screen to enhance poly (ADP-ribose) polymerase (PARP) inhibitor efficacy in ovarian cancer. 2023 ·Journal of Clinical Oncology ·(unknown),Santosh K. Dasari,Reid T. Powell,(unknown),Mary Sobieski,Clifford Stephan,(unknown),Timothy A. Yap,Amir A. Jazaeri,Shannon N. Westin,Anil K. Sood	0
12	Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo 2023 ·PLoS ONE ·Fan Fan,Susmita Ghosh,Reid T. Powell,Jason Roszik,(unknown),Mary Sobieski,Alexey V. Sorokin,Clifford Stephan,Scott Kopetz,Lee M. Ellis,Rajat Bhattacharya	6
13	Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus–Driven Cancers 2022 ·Clinical Cancer Research ·Soma Ghosh,Tuhina Mazumdar,Wei Xu,Reid T. Powell,Clifford Stephan,Li Shen,(unknown),Curtis R. Pickering,(unknown),Jing Wang,Mitchell J. Frederick,Faye M. Johnson	13
14	Screening of GPCR drugs for repurposing in breast cancer 2022 ·Frontiers in Pharmacology ·(unknown),Raksha R. Bhat,Reid T. Powell,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Mary Sobieski,(unknown),Jun Hyoung Park,(unknown),Benny Abraham Kaipparettu,Richard A. Bond,Michael D. Johnson,Clifford Stephan,Meghana V. Trivedi	10
15	Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition 2021 ·Nature Communications ·Na Zhao,Reid T. Powell,(unknown),(unknown),Kevin Roarty,Fabio Stossi,(unknown),Michael J. Toneff,Hannah L. Johnson,Sendurai A. Mani,Philip Jones,Clifford Stephan,Jeffrey M. Rosen	43
16	Author Correction: Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells 2021 ·Scientific Reports ·(unknown),Dimuthu Perera,Reid T. Powell,(unknown),Durga Nand Tripathi,Yong Sung Park,Michael A. Mancini,Peter Davies,Clifford Stephan,Cristian Coarfa,Ruhee Dere	3
17	High-throughput screening against protein:protein interaction interfaces reveals anti-cancer therapeutics as potent modulators of the voltage-gated Na+ channel complex 2019 ·Scientific Reports ·(unknown),Oluwarotimi Folorunso,Nghi Nguyen,A.K. Singh,Daniela D’Amico,Reid T. Powell,David Brunell,John Allen,Clifford Stephan,Fernanda Laezza	12
18	Bexarotene – a novel modulator of AURKA and the primary cilium in VHL-deficient cells 2018 ·Journal of Cell Science ·(unknown),Reid T. Powell,Clifford Stephan,Iván P. Uray,(unknown),Menuka Karki,Durga Nand Tripathi,Yong Sung Park,Michael A. Mancini,Peter J. Davies,Ruhee Dere	5
19	The role of hepatocyte nuclear factor 1 homeobox B (HNF1B) loss in chromophobe RCC (ChRCC) development 2017 ·Annals of Oncology ·Eric Jonasch,Gregory N. Fuller,Ian E. McCutcheon,Zhenfeng Ding,Lanlan Zhou,X Liu,Wen Kong,Reid T. Powell,(unknown),Nizar M. Tannir,W. Kimryn Rathmell,Baijun Dong,Surena F. Matin,Xiaowen Tong,Yiran Huang,Pan Tong,(unknown),Cheryl L. Walker,Mianen Sun	2
20	Methylated α-tubulin antibodies recognize a new microtubule modification on mitotic microtubules 2016 ·mAbs ·In Young Park,(unknown),Durga Nand Tripathi,Reid T. Powell,Ruhee Dere,Esteban Terzo,W. Kimryn Rathmell,Cheryl L. Walker	12

About Reid T. Powell

Reid T. Powell is a scholar working on Oncology, Cell Biology and Biophysics, having authored 38 papers that have together received 949 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Microtubule and mitosis dynamics (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (174 citations), Molecular Biology (604 citations) and Cell Biology (115 citations). Reid T. Powell has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Cheryl L. Walker, Durga Nand Tripathi, Ruhee Dere, Arvind Rao, Raj K. Pandita, Jacqueline Tait-Mulder, Vijaya Charaka, Jiangwei Zhang, Angela Alexander and Ji‐Hoon Lee. Their work appears in journals such as Cell, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact